Published in Thromb Diath Haemorrh on April 30, 1969
Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev (1988) 6.08
Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc Natl Acad Sci U S A (1979) 4.71
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost (1981) 4.39
Gene organization and structure of two transcriptional units from Methanococcus coding for ribosomal proteins and elongation factors. Can J Microbiol (1989) 3.38
Classification and surgical treatment of incisional hernia. Results of an experts' meeting. Langenbecks Arch Surg (2001) 3.01
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med (2000) 2.86
Cohesive sites on the deoxyribonucleic acids from several temperate coliphages. J Mol Biol (1966) 2.75
PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J (1998) 2.62
Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol Cell Biol (1998) 2.39
Identification and characterization of an immunologically conserved adenovirus early region 11,000 Mr protein and its association with the nuclear matrix. J Mol Biol (1982) 2.36
Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc (2008) 2.29
Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost (1996) 2.07
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Res (2001) 1.98
Thoracic endoscopic sympathectomy in palmar and axillary hyperhidrosis. Arch Surg (1978) 1.97
Characterization of human p53 antigens employing primate specific monoclonal antibodies. Virology (1983) 1.78
Antithrombin III deficiency and thromboembolism. Clin Haematol (1981) 1.76
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
[Cloning of the hepatitis B virus genome in Escherichia coli]. C R Acad Sci Hebd Seances Acad Sci D (1978) 1.62
Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton. Curr Biol (1998) 1.49
Solid tumors and factor VIII antibodies. Thromb Haemost (1999) 1.48
Transcriptional stimulation by CaPO4-DNA precipitates. Nucleic Acids Res (1988) 1.47
Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol (1999) 1.46
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis? Int Arch Allergy Immunol (1998) 1.44
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol (2002) 1.44
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Ann Intern Med (1990) 1.44
Motor cortex disinhibition in acute stroke. Clin Neurophysiol (2000) 1.40
A comparison of the Bethesda and New Oxford methods of factor VIII antibody assay. Thromb Haemost (1982) 1.39
Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features. Thromb Haemost (2000) 1.39
Thrombocytopenia associated with low-molecular-weight heparin. Lancet (1991) 1.39
[Radiologic staging of thoracic and abdominal tumors in childhood]. Radiologe (1999) 1.38
Novel CBF beta-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16. Blood (1995) 1.38
Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Thromb Haemost (1983) 1.34
Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis (1985) 1.34
Interleukin-3 is a differentiation factor for human basophils. Blood (1989) 1.34
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood (1989) 1.33
Glycosylated hemoglobins (GHb): an index of red cell survival. Blood (1982) 1.32
Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs. A critical analysis and long-term results of 480 operations. Ann Surg (1994) 1.31
Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol (1998) 1.28
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant (2005) 1.28
Bacteriophage lambda-E. coli K12 vector-host system for gene cloning and expression under lactose promoter control. II. DNA fragment insertion at the vicinity of the lac UV5 promoter. Mol Gen Genet (1979) 1.27
Acquired inhibitors in nonhemophilic patients. Haemostasis (1974) 1.26
Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci U S A (1989) 1.26
Peripheral nerve lesions in haemophilia. J Neurol (1981) 1.25
Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr (1982) 1.25
Variations of intramolecular ligation rates allow the detection of protein-induced bends in DNA. EMBO J (1986) 1.24
[An up-to-now unknown way of centriole propagation]. Z Zellforsch Mikrosk Anat (1965) 1.24
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis (1980) 1.22
Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma (2000) 1.16
A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem (1988) 1.15
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant (2002) 1.14
Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci U S A (1991) 1.13
Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery (1986) 1.12
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood (1994) 1.12
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ (2009) 1.12
Protein C deficiency in two Austrian families. Thromb Haemost (1983) 1.12
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J Clin Oncol (1994) 1.12
1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol (2000) 1.10
Failure to detect IL-3-binding sites on human mast cells. J Immunol (1990) 1.10
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology (1996) 1.09
Hemophilia and thrombocytopenia in a patient with impaired cellular immunity. A case report. Blut (1984) 1.08
[Gangrene following erroneous intra-arterial injection of dicloxacillin]. Dtsch Med Wochenschr (1971) 1.08
Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study. Thromb Haemost (1979) 1.08
Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen. Cancer Res (1988) 1.08
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood (1995) 1.07
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen. J Immunol (1993) 1.07
Clinical significance of lupus anticoagulants in children. J Pediatr (1999) 1.07
Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med (1988) 1.06
Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. Bone Marrow Transplant (1990) 1.06
Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost (1999) 1.05
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol (1995) 1.05
Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6. J Biol Chem (2001) 1.05
Acquired factor V inhibitors. Baillieres Clin Haematol (1998) 1.04
Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost (1995) 1.04
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost (1998) 1.03
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol (1993) 1.03
Bacteriophage lambda-E. coli K12 vector-host system for gene cloning and expression under lactose promoter control: I. DNA fragment insertion at the lacZ EcoRI restriction site. Mol Gen Genet (1979) 1.02
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse. Leukemia (2004) 1.02
The coagulation disorder of orthotopic hepatic transplantation. Semin Thromb Hemost (1977) 1.02
Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Thromb Haemost (1995) 1.00
Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol (1998) 1.00
Recombinant human erythropoietin and hematopoietic progenitor cells in vivo. Blood (1989) 0.99
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol (1996) 0.98
IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol (1991) 0.98
Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases. J Med Chem (2000) 0.98
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood (2001) 0.98
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes. Leuk Res (2001) 0.97
Hepatic perfusion after liver transplantation: noninvasive measurement with dynamic single-section CT. Radiology (1998) 0.97
[On the ultrastructure of myoclonic bodies]. Acta Neuropathol (1967) 0.97
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. Bone Marrow Transplant (1998) 0.97
Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost (1985) 0.97
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol (2001) 0.96
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia (2004) 0.96
[Late lesions of the trachea following tracheotomy. X-ray and clinical studies]. Anaesthesist (1967) 0.96
A new type of coagulation inhibitor. Thromb Diath Haemorrh (1969) 0.96
IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites. J Immunol (1990) 0.95
The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thromb Haemost (1997) 0.95